ASH 2020 | Lymphoma tumor microenvironment updates
Stephen Ansell
• 4 Dec 2020
Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MI, provides an overview of our current understanding of the tumor microenvironment. While there are now a variety of strategies used to target the tumor cell, Prof Ansell asserts that the future is going to be a combination of these. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.
Disclosures
Research funding: Bristol Myers Squibb, Seattle Genetics, ADC Therapeutics, Affimed, Trillium, AI Therapeutics, Regeneron
